Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is -6.65% vs -0.25% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 525.00% vs -33.33% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 1,800.00% vs -75.00% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 0.00% vs -100.00% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Shanghai Rendu Biotechnology Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -6.65% vs -0.25% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -13.86% vs 18.60% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 525.00% vs -33.33% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 1,566.67% vs -83.33% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 1,800.00% vs -75.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 1,050.00% vs -140.00% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 0.00% vs -100.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 0.00% vs -100.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






